Published literature, mechanisms, and protocols, organized by compound. Educational reference, not medical advice.
A classification and literature article on CJC-1295 (a GHRH analogue) and ipamorelin (a ghrelin receptor agonist): why two compounds acting on two different receptors are searched together, what published studies of GHRH plus GHRP co-administration reported, and whether the specific pair has ever been trialed.
Tesamorelin is a GHRH-receptor analogue and ipamorelin is a ghrelin-receptor (GHS-R1a) agonist. This article classifies the two compounds, reports the published research on GHRH analogues co-administered with GHRPs, and states plainly that no clinical trial of tesamorelin with ipamorelin has been published.
A bibliographic summary of published research on sermorelin (GRF 1-29): diagnostic stimulation testing, pediatric growth-hormone-deficiency trials, GH-axis pharmacodynamics, and studies in older adults. Educational reference.
A neutral research overview of sermorelin (GRF 1-29): its chemistry, growth-hormone-releasing-hormone classification, reported mechanism, published research record, and regulatory history. Educational reference.
An educational reference summarizing peer-reviewed studies on DSIP (delta sleep-inducing peptide), a nonapeptide first isolated in 1977, spanning isolation and sequencing work, preclinical neuropharmacology, and clinical investigation.
A trial-by-trial reading of the tirzepatide literature, organized as three research waves: bench pharmacology and cryo-EM structure, the SURPASS diabetes program, and the SURMOUNT weight-management program. Educational reference.
A structured bibliographic survey of the Thymosin Alpha-1 research record, from the 1970s discovery work through chronic-hepatitis randomized trials, TLR-pathway immunomodulation studies, and contemporary immuno-oncology review literature. Educational reference.
An annotated tour of the tesamorelin literature organized as two research programs: the pivotal HIV visceral-adiposity trials and the later pivot to hepatic-fat and GH-axis pharmacodynamics. Educational reference.
A structured review of the peer-reviewed literature behind TB-500, tracing the actin-sequestration biochemistry that produced the LKKTETQ fragment, the ophthalmic and cardiac studies conducted on full-length thymosin beta-4, and the analytical work that characterized the fragment itself, with attention to where fragment and parent-protein evidence diverge. Educational reference.
Published SS-31 (elamipretide) research traced from its founding inner-membrane biophysics through the cardiolipin hypothesis, mitochondrial interactome mapping, ex vivo human cardiac tissue, and rare-disease clinical programs, with citations to primary literature.
A structured survey of PubMed-indexed Semax research, organized around neurotrophin gene expression, the intact-peptide versus Pro-Gly-Pro metabolite question, monoaminergic microdialysis data, ischemia-model transcriptomics, and copper(II) coordination chemistry.
A program-by-program bibliographic reference to the semaglutide clinical literature, tracing how the SUSTAIN, PIONEER, STEP, and SELECT trials were designed and what their primary endpoints reported, each attributed to its primary peer-reviewed publication.
A structured survey of the peer-reviewed Selank literature, from its tuftsin origins through enkephalinase pharmacology, GABAergic gene-expression studies, hippocampal transcriptomics, and the comparative clinical trial behind its Russian registration.
A bibliographic summary of the primary peer-reviewed literature on retatrutide (LY3437943), tracing the compound from its founding discovery paper through cryo-EM structural biology and its phase 1 and phase 2 clinical trial program. Educational reference.
A research-library summary of the published bremelanotide (PT-141) literature, organized by its melanotan II lineage, the intranasal male-population trials, and the subcutaneous RECONNECT phase 3 program that supported FDA approval. Educational reference.
A study-by-study survey of the peer-reviewed literature on the EDR tripeptide (Pinealon), organized by experimental modality: intracellular localization and DNA-interaction work, oxidative-stress cell studies, rodent disease models, and computational promoter-docking analyses.
Peer-reviewed oxytocin research summarized along its historical arc, from du Vigneaud's landmark synthesis to OXTR structural biology, obstetric trials, cardiovascular physiology, and neuroimaging paradigms. Educational reference.
An evidence map of the NAD+ literature organized by what each study could actually measure: the biochemistry that defined NAD+ as a signaling substrate, the divergence between NR and NMN precursor pharmacokinetics, blood-based versus tissue-biopsy human trials, and the positive-versus-null result split that now shapes trial design. Educational reference.
A study-by-study reading of the Semax literature centered on the doubly terminal-modified variant: the copper-coordination work on N-acetyl Semax, N-terminal structure–activity findings, neurotrophin gene-expression time courses, and ischemia-model transcriptomics. Educational reference.
A structured review of the peer-reviewed Selank literature organized by its two core mechanistic threads, enkephalin-degrading enzyme inhibition and GABAergic transcriptional modulation, with explicit notation of where findings rest on the parent compound versus the amidated analog. Educational reference.
A research-library survey of the published Melanotan-2 (MT-II) literature, tracing the compound's role as a conformationally constrained melanocortin probe across in vitro receptor pharmacology, rodent hypothalamic circuit studies, a single 1990s human pilot, and post-market clinical case reports. Educational reference.
A structured survey of the peer-reviewed MOTS-c literature, organized by the three molecular mechanisms uncovered since its 2015 discovery as a mitochondrial-derived peptide: folate-AICAR-AMPK signaling, stress-induced nuclear translocation, and CK2 binding, alongside exercise and human observational data.
A literature-anchored summary of published mazdutide (IBI362 / LY3305677) research, tracing how a synthetic GLP-1R/GCGR dual agonist moved from receptor pharmacology through early-phase Chinese clinical trials, with attention to the glucagon-associated signals that distinguish it from single-incretin agonists. Educational reference.
A thematic bibliographic summary of peer-reviewed preclinical KPV (Lys-Pro-Val) research, organized around three recurring questions: receptor independence, cellular uptake and engineered delivery, and structural stability. Educational reference.
A source-attributed summary of kisspeptin-10 (KP-10) research, tracing the compound from KISS1R receptor pharmacology and structure-activity mapping through KNDy-neuron circuitry to controlled human neuroendocrine studies and open questions. Educational reference.
A source-by-source survey of ipamorelin's peer-reviewed literature, traced from the 1998 Novo Nordisk discovery papers through the ghrelin-mimetic gastrointestinal program and a phase 2 postoperative-ileus trial. Educational reference.
A structured bibliographic review of the peer-reviewed IGF-1 LR3 literature, organized by the analog's distinguishing pharmacology: reduced IGFBP binding, its use in rodent potency comparisons, and its adoption as a serum-free cell-culture supplement. Educational reference.
A structured survey of the hexarelin research literature, organized around its GH-releasing pharmacology and the CD36-linked cardiovascular, metabolic, and neuroprotective models that have shaped later work. Educational reference.
A structured review of peer-reviewed glutathione research, organized by the questions each body of work set out to answer: biosynthesis and pool size, intracellular compartmentalization, GPx enzymatic chemistry, S-glutathionylation signaling, and controlled oral-supplementation trials.
A citation-based survey of the published GHRP-6 literature, tracing the peptide from its 1984 pharmacological characterization through the cloning of its receptor and the discovery of ghrelin. Educational reference.
A bibliographic review of peer-reviewed GHRP-2 (pralmorelin) research, organized by the research communities that studied it: receptor pharmacology, human neuroendocrine work, the Japanese diagnostic dossier, and anti-doping detection chemistry. Educational reference.
A citation-organized walkthrough of the GHK-Cu research record, from the 1973 serum-fraction isolation through fibroblast collagen assays, the 1994 wound-chamber study, and later transcriptomic and pulmonary-model work. Educational reference.
A source-organized survey of the Epithalon (AEDG tetrapeptide) and Epithalamin extract literature, separating cell-culture telomerase and chromatin work from rodent lifespan experiments and long-term human observational cohorts, with the documented gaps noted. Educational reference.
A research-library map of how the fragmented GHRH-analog literature (the tetrasubstituted GRF(1-29) backbone, sermorelin, and the DAC-bearing variant) applies to CJC-1295 without DAC, with each study's scope flagged. Educational reference.
What the peer-reviewed record actually reports on CJC-1295 with DAC, from the albumin-conjugation chemistry that defines the "DAC" designation to the human single-administration GH and IGF-1 kinetics measured by the original ConjuChem investigators.
A literature-anchored walk through cagrilintide's published record, from the acylated amylin-analog design that solved fibrillation, to the Phase 1b and Phase 2 combination trials, the Phase 3 REDEFINE readouts, and cryo-EM receptor structures. Educational reference.
A critical bibliographic tour of the BPC-157 literature: its single-lineage provenance, the gastrointestinal and tendon-fibroblast studies, the nitric-oxide hypothesis, pharmacokinetic data, and the unresolved replication and human-evidence questions.
A thread-by-thread survey of the peer-reviewed AOD9604 literature: the antilipogenesis-versus-lipolysis question, the β3-adrenergic receptor line of study, the oral-activity puzzle, and the consolidated six-trial human safety dataset.
